Plerixafor-fig1 (Plerixafor Fig1)
Plerixafor Solution
Product Images NDC 55150-356
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Plerixafor (NDC 55150-356). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Eugia Us Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Package Label-principal Display Panel (24 mg per 1.2 mL (20 mg/mL) Container-Carton Label)
This text contains information about a medication called Plerixafor. It is an injection that is administered subcutaneously, with a concentration of 24 mg per 1.2 mL (20 mg/mL). The medication is provided in a single-dose vial, and any unused portion should be discarded. The package insert should be consulted for dosage and administration instructions. Each mL of the solution contains 20 mg of Plerixafor. The solution also contains 5.9 mg of sodium chloride and is adjusted to a pH of 6.0 to 7.5. The medication does not contain preservatives. It should be stored at a temperature of 25°C, with excursions permitted between 15°C and 30°C. The vial stopper is latex-free. The medication is distributed by Eugia US LLC and made in India.*
Structural Formula (Plerixafor Str)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
